News
8h
inews.co.uk on MSNHow a UK big pharma exec was arrested in China – and hasn’t been heard from sinceThe China chief of AstraZeneca - Britain's biggest company - was arrested months ago, but his condition and whereabouts ...
U.S. bank Wells Fargo has suspended all travel to China after one of its employees was barred from leaving the country, a ...
Sino Biopharmaceuticals plans to pay up to $950.9 million to acquire LaNova Medicines, which previously licensed drugs to ...
The PD-1xVEGF dealmaking wave that has captivated Western pharma companies is now surging within China. | Sino Biopharm said ...
Following a successful patent defense case upheld by China’s IP authority, AstraZeneca invested nearly 9 billion yuan ($1.24 billion) to establish two global R&D centres in Beijing and Shanghai, said ...
Months after announcing an M&A deal with AstraZeneca, EsoBiotec has released the first small slice of data on the cell ...
4d
GlobalData on MSNSino Biopharma spends $951m to acquire China-based LaNova MedicinesBoth AstraZeneca and MSD have secured lucrative licensing deals for two of LaNova’s oncology assets in recent years.
Top regulators like the US FDA and EMA are fast-tracking more Chinese drugs, granting priority review and breakthrough ...
AstraZeneca is in advanced talks with Summit Therapeutics over a potential $15 billion deal for the lung cancer drug ivonescimab.
AstraZeneca (LSE:AZN) received EU approval for its cancer treatment Imfinzi, marking a significant product-related milestone.
ORPATHYS ® is approved in China and is marketed by AstraZeneca for the treatment of adult patients with locally advanced or metastatic NSCLC with MET exon 14 skipping alteration, representing the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results